EUVIMEDEUVIMED entdecken
Crossref

Relationship Between IL-10 Single Nucleotide Polymorphisms (rs1800871, rs1800872, and rs1800896) and the Severity of COVID-19

Hossein Azadinejad iD, Parisa Feizollahi, Alireza Rezaeimanesh, Farhad Salari, Ali Gorgin Karaji

Genetic Testing and Molecular Biomarkers · 01.11.2024 · 28 (11) · 438-444

DOI: 10.1089/gtmb.2024.0276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetic Testing and Molecular Biomarkers, erschienen am 01.11.2024. Verfasst von Hossein Azadinejad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran. Hauptthemen laut MEDLINE: Polymorphism, Single Nucleotide, COVID-19, Interleukin-10, Severity of Illness Index. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Interleukin-10 (IL-10) is an anti-inflammatory cytokine whose levels are elevated in patients with severe COVID-19. IL-10 polymorphisms may play a role in increasing IL-10 levels and the severity of COVID-19. This study aimed to investigate the relationship between IL-10 single nucleotide polymorphisms (SNPs) (rs1800896 [-1082 C G], and rs1800872 [-592 T > G]) and the severity of COVID-19 in patients from Kermanshah Province, Iran.

Methods

A total of 150 patients with mild COVID-19 (84 men and 66 women aged 40.1 ± 12.44 years) and 143 patients with severe COVID-19 (76 men and 67 women aged 61.04 ± 15.65 years) participated in this study. Blood samples were collected from the patients, DNA was extracted, and the genotype of each SNPs was determined using the polymerase chain reaction-restriction fragment length polymorphism method.

Result

The results of this study did not show a significant relationship between the genotypes of the three studied SNPs and the severity of COVID-19 (p > 0.05).

Conclusion

According to our findings, these SNPs were not associated with COVID-19 severity in patients in Kermanshah.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymorphism, Single NucleotideCOVID-19Interleukin-10Severity of Illness IndexSARS-CoV-2Genetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedIranAdultAgedGenotypeGene FrequencyAlleles

Stichwörter der Autor:innen

COVID-19interleukin-10polymerase chain reaction–restriction fragment length polymorphismsingle nucleotide polymorphism

Substanzen

Interleukin-10IL10 protein, human

Autor:innen und Institutionen

  • Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Department of Immunology, School of Medicine, Tarbiat Modares University of Medical Science, Tehran, Iran.

ORCID-Profile: Hossein Azadinejad

Zitieren

APA

Azadinejad, H., Feizollahi, P., Rezaeimanesh, A., Salari, F., & Gorgin Karaji, A. (2024). Relationship Between IL-10 Single Nucleotide Polymorphisms (rs1800871, rs1800872, and rs1800896) and the Severity of COVID-19. Genetic Testing and Molecular Biomarkers, 28(11), 438-444. https://doi.org/10.1089/gtmb.2024.0276

Vancouver

Azadinejad H, Feizollahi P, Rezaeimanesh A, Salari F, Gorgin Karaji A. Relationship Between IL-10 Single Nucleotide Polymorphisms (rs1800871, rs1800872, and rs1800896) and the Severity of COVID-19. Genetic Testing and Molecular Biomarkers. 2024;28(11):438-444. doi:10.1089/gtmb.2024.0276

BibTeX
@article{Azadinejad2024,
  author = {Azadinejad, Hossein and Feizollahi, Parisa and Rezaeimanesh, Alireza and Salari, Farhad and Gorgin Karaji, Ali},
  title = {Relationship Between IL-10 Single Nucleotide Polymorphisms (rs1800871, rs1800872, and rs1800896) and the Severity of COVID-19},
  journal = {Genetic Testing and Molecular Biomarkers},
  year = {2024},
  volume = {28},
  number = {11},
  pages = {438--444},
  doi = {10.1089/gtmb.2024.0276}
}
Kostenlos starten →